John Walter Jr Hanna

CareDx CEO John Walter Jr Hanna sells 118,000 shares ($4.5M) via scheduled 10b5-1 plan; holds 653.4K shares post-sale plus 512,706 options.

President and CEO John Walter Jr Hanna executed two separate sales totaling 118,000 shares for $4,458,636.60 on 2026-07-16, reducing his non-derivative holdings by 15.3% to 653,448 shares. This transaction is part of a pre-arranged 10b5-1 trading plan adopted on 2025-12-12, meaning it was scheduled rather than discretionary. The stock traded at $39.73 at the time of filing, within 1.8% of its 52-week high of $40.47, and the company has appreciated 69.2% over the prior 30 days and 85.5% over 90 days. His prior three trades at CareDx have included sales on 2026-06-29 and 2026-06-26, also scheduled activity; his 2026-06-11 sale showed a 30-day return of +18.7% (a measurable outcome). The company remains unprofitable on a full-year basis despite achieving 13.8% annual revenue growth and $117.7M in latest-quarter revenue. The insider retains 512,706 shares in employee stock options, so his total economic exposure remains material.

CareDx CEO John Walter Jr Hanna executes 2 scheduled 10b5-1 sales totaling 40,000 shares for $1,169,735.60; retains 661,959 shares plus 3,358,400 derivative options.

President and CEO John Walter Jr Hanna executed two separate sales totaling 40,000 shares for $1,169,735.60 under a pre-arranged 10b5-1 trading plan adopted on 2025-12-12, reducing his non-derivative holdings from 701,959 shares to 661,959 shares. His post-transaction holdings remain substantial at 661,959 non-derivative shares plus 3,358,400 derivative securities (employee stock options), indicating continued material ownership. The sale occurred in the context of a 30-day stock price appreciation of +24.9% and a 90-day appreciation of +59.5%, positioning the sales near the 52-week high of $29.58. This represents his second trade at CDNA, following a June 11, 2026 sale whose outcome is not yet measurable.

CEO John Walter Jr Hanna sells 21,998 shares of CDNA at $24.02 under 10b5-1 plan adopted 2024-12-13

John Walter Jr Hanna, President and CEO, sold 21,998 shares of CareDx, Inc. at $24.02 per share on 2026-06-11 under a pre-arranged 10b5-1 trading plan adopted on 2024-12-13. This was a scheduled, non-discretionary transaction. Post-transaction holdings remain substantial at 649,642 shares. The stock trades near its 52-week high of $24.13 and has appreciated 20.6% over 30 days and 36.8% over 90 days, reflecting recent momentum. The company generated $117.7M in latest quarterly revenue with 13.8% annual revenue growth, though it remains unprofitable on a full-year basis. The scheduled nature of this transaction precludes attribution to discretionary strategic reasoning.